Kelly Cooper Younge1, Yizhen Wang2, John Thompson3, Julia Giovinazzo3, Marisa Finlay3, Raxa Sankreacha2. 1. Department of Radiation Oncology, University of Michigan, Ann Arbor, Michigan. Electronic address: kyounge@med.umich.edu. 2. Department of Radiation Oncology, University of Michigan, Ann Arbor, Michigan. 3. Department of Radiation Oncology, Trillium Health Partners - Credit Valley Hospital Site, Mississauga Halton/Central West Regional Cancer Program, Mississauga, ON, Canada.
Abstract
PURPOSE: To improve the safety and efficiency of a new stereotactic radiosurgery program with the application of failure mode and effects analysis (FMEA) performed by a multidisciplinary team of health care professionals. METHODS AND MATERIALS: Representatives included physicists, therapists, dosimetrists, oncologists, and administrators. A detailed process tree was created from an initial high-level process tree to facilitate the identification of possible failure modes. Group members were asked to determine failure modes that they considered to be the highest risk before scoring failure modes. Risk priority numbers (RPNs) were determined by each group member individually and then averaged. RESULTS: A total of 99 failure modes were identified. The 5 failure modes with an RPN above 150 were further analyzed to attempt to reduce these RPNs. Only 1 of the initial items that the group presumed to be high-risk (magnetic resonance imaging laterality reversed) was ranked in these top 5 items. New process controls were put in place to reduce the severity, occurrence, and detectability scores for all of the top 5 failure modes. CONCLUSIONS: FMEA is a valuable team activity that can assist in the creation or restructuring of a quality assurance program with the aim of improved safety, quality, and efficiency. Performing the FMEA helped group members to see how they fit into the bigger picture of the program, and it served to reduce biases and preconceived notions about which elements of the program were the riskiest.
PURPOSE: To improve the safety and efficiency of a new stereotactic radiosurgery program with the application of failure mode and effects analysis (FMEA) performed by a multidisciplinary team of health care professionals. METHODS AND MATERIALS: Representatives included physicists, therapists, dosimetrists, oncologists, and administrators. A detailed process tree was created from an initial high-level process tree to facilitate the identification of possible failure modes. Group members were asked to determine failure modes that they considered to be the highest risk before scoring failure modes. Risk priority numbers (RPNs) were determined by each group member individually and then averaged. RESULTS: A total of 99 failure modes were identified. The 5 failure modes with an RPN above 150 were further analyzed to attempt to reduce these RPNs. Only 1 of the initial items that the group presumed to be high-risk (magnetic resonance imaging laterality reversed) was ranked in these top 5 items. New process controls were put in place to reduce the severity, occurrence, and detectability scores for all of the top 5 failure modes. CONCLUSIONS: FMEA is a valuable team activity that can assist in the creation or restructuring of a quality assurance program with the aim of improved safety, quality, and efficiency. Performing the FMEA helped group members to see how they fit into the bigger picture of the program, and it served to reduce biases and preconceived notions about which elements of the program were the riskiest.
Authors: B Ibanez-Rosello; J A Bautista; J Bonaque; J Perez-Calatayud; A Gonzalez-Sanchis; J Lopez-Torrecilla; L Brualla-Gonzalez; T Garcia-Hernandez; A Vicedo-Gonzalez; D Granero; A Serrano; B Borderia; C Solera; J Rosello Journal: Clin Transl Oncol Date: 2017-08-04 Impact factor: 3.405
Authors: M Saiful Huq; Benedick A Fraass; Peter B Dunscombe; John P Gibbons; Geoffrey S Ibbott; Arno J Mundt; Sasa Mutic; Jatinder R Palta; Frank Rath; Bruce R Thomadsen; Jeffrey F Williamson; Ellen D Yorke Journal: Med Phys Date: 2016-07 Impact factor: 4.071
Authors: Ivan Veronese; Elena De Martin; Anna Stefania Martinotti; Maria Luisa Fumagalli; Cristina Vite; Irene Redaelli; Tiziana Malatesta; Pietro Mancosu; Giancarlo Beltramo; Laura Fariselli; Marie Claire Cantone Journal: Radiat Oncol Date: 2015-06-13 Impact factor: 3.481
Authors: Bradley W Schuller; Angi Burns; Elizabeth A Ceilley; Alan King; Joan LeTourneau; Alexander Markovic; Lynda Sterkel; Brigid Taplin; Jennifer Wanner; Jeffrey M Albert Journal: J Appl Clin Med Phys Date: 2017-09-25 Impact factor: 2.102
Authors: Blanca Ibanez-Rosello; Juan Antonio Bautista-Ballesteros; Jorge Bonaque; Francisco Celada; Françoise Lliso; Vicente Carmona; Jose Gimeno-Olmos; Zoubir Ouhib; Joan Rosello; Jose Perez-Calatayud Journal: J Contemp Brachytherapy Date: 2016-12-20
Authors: Prema Rassiah; Fan-Chi Frances Su; Y Jessica Huang; Dan Spitznagel; Vikren Sarkar; Martin W Szegedi; Hui Zhao; Adam B Paxton; Geoff Nelson; Bill J Salter Journal: J Appl Clin Med Phys Date: 2020-06-25 Impact factor: 2.102